Patents by Inventor Urs Regenass

Urs Regenass has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMBINATION COMPRISING PACLITAXEL FOR TREATING OVARIAN CANCER
    Publication number: 20130317048
    Abstract: The invention relates to the combination of an endothelin receptor antagonist of formula (I) with paclitaxel, and in particular to this combination for therapeutic use, simultaneously, separately or over a period of time, in the treatment of ovarian cancer.
    Type: Application
    Filed: August 1, 2013
    Publication date: November 28, 2013
    Applicant: Actelion Pharmaceuticals Ltd.
    Inventors: Martine Clozel, Urs Regenass
  • COMBINATIONS COMPRISING MACITENTAN FOR THE TREATMENT OF GLIOBLASTOMA MULTIFORME
    Publication number: 20130310407
    Abstract: The invention relates to the use of macitentan in combination with a cytotoxic therapy agent (such as temozolomide or paclitaxel), with radiotherapy or with both a cytotoxic therapy agent and radiotherapy, in the treatment of malignant glioma, in particular glioblastoma multiforme.
    Type: Application
    Filed: February 3, 2012
    Publication date: November 21, 2013
    Applicant: ACTELION PHARMACEUTICALS LTD.
    Inventor: Urs Regenass
  • Combination comprising macitentan and paclitaxel for treating multi-drug resistant ovarian cancer
    Patent number: 8541433
    Abstract: The invention relates to the combination of an endothelin receptor antagonist of formula (I) with paclitaxel, and in particular to this combination for therapeutic use, simultaneously, separately or over a period of time, in the treatment of ovarian cancer.
    Type: Grant
    Filed: February 19, 2009
    Date of Patent: September 24, 2013
    Assignee: Actelion Pharmaceuticals, Ltd.
    Inventors: Martine Clozel, Urs Regenass
  • Combination Comprising Paclitaxel for Treating Ovarian Cancer
    Publication number: 20100311774
    Abstract: The invention relates to the combination of an endothelin receptor antagonist of formula (I) with paclitaxel, and in particular to this combination for therapeutic use, simultaneously, separately or over a period of time, in the treatment of ovarian cancer.
    Type: Application
    Filed: February 19, 2009
    Publication date: December 9, 2010
    Inventors: Martine Clozel, Urs Regenass
  • Carbazole derivatives as agents against multi-drug resistance
    Patent number: 5827846
    Abstract: The utility of known and novel staurosporin derivatives of formula I ##STR1## wherein R.sub.1 is formyl, an aliphatic hydrocarbon radical having up to 29 carbon atoms that is unsubstituted or substituted by aryl, or is an aryl radical,R.sub.2 is hydrogen, C.sub.1 -C.sub.5 alkyl, benzoyl, lower alkanoyl or .alpha.-aminoacyl having a free or protected amino group, andR.sub.3 is hydrogen, hydroxy, lower alkoxy or oxo,or whereinR.sub.1 is methoxycarbonylmethyl,R.sub.2 is benzoyl, andR.sub.3 is hydrogen,for avoiding or removing multi-drug resistance to anti-tumour agents, such as vinblastine or adriamycin, is described.
    Type: Grant
    Filed: November 27, 1996
    Date of Patent: October 27, 1998
    Assignee: Novartis Corp.
    Inventors: Urs Regenass, Giorgio Caravatti, Oskar Wacker
  • Use of compositions for combating tumour diseases
    Patent number: 5663168
    Abstract: The present invention relates to the use of inhibitors of HIV aspartate proteases, such as HIV-1- or HIV-2-protease, and their salts and to prodrugs for inhibiting the growth of tumors, especially those tumors which do not respond to the inhibition of HIV aspartate proteases themselves, and in the preparation of pharmaceutical compositions intended for use in the prophylaxis and especially the treatment of tumor diseases, and to methods and pharmaceutical compositions for the treatment of tumors with those compounds.
    Type: Grant
    Filed: May 16, 1994
    Date of Patent: September 2, 1997
    Assignee: CIBA-Geigy Corporation
    Inventors: Johannes Rosel, Urs Regenass, Marc Lang, Guido Bold, Frederic Cumin